Frisch Nicholas B, Wessell Nolan, Jildeh Toufic R, Greenstein Alexander, Trent Guthrie S
Ascension Crittenton Hospital, Rochester, Michigan.
Department of Orthopaedic Surgery, Henry Ford Health System, Detroit, Michigan.
J Surg Orthop Adv. 2018 Fall;27(3):226-230.
Chronic kidney disease (CKD) is a documented risk factor for hip fracture mortality. CKD represents a spectrum of disease and there is no clear evidence differentiating the risk between patients with early versus end-stage CKD. The purpose of this study was to explore the relationship between the stages of CKD and mortality following operative treatment of hip fractures. Four hundred ninety-eight patients were analyzed; 81 were identified as having CKD. This study followed overall patient mortality at 90 days and at 1 year postoperatively. Patients with CKD had higher mortality at both 90 days and 1 year compared with those without CKD (hazard ratio 1.69 and 1.84, respectively). In a subgroup analysis to determine the effect of CKD stage, only stage 3 CKD was associated with increased mortality. The orthopaedic surgeon can play a key role in identifying at-risk patients and help to facilitate additional management. (Journal of Surgical Orthopaedic Advances 27(3):226-230, 2018).
慢性肾脏病(CKD)是髋部骨折死亡率的一个已被证实的风险因素。CKD代表一系列疾病,目前尚无明确证据区分早期CKD患者与终末期CKD患者之间的风险差异。本研究的目的是探讨CKD分期与髋部骨折手术治疗后死亡率之间的关系。对498例患者进行了分析;其中81例被确定患有CKD。本研究跟踪了患者术后90天和1年的总体死亡率。与无CKD的患者相比,CKD患者在90天和1年时的死亡率均更高(风险比分别为1.69和1.84)。在一项确定CKD分期影响的亚组分析中,只有3期CKD与死亡率增加相关。骨科医生在识别高危患者方面可发挥关键作用,并有助于促进进一步的管理。(《外科骨科进展杂志》27(3):226 - 230, 2018)